O
OrSense
Biotech & Life Sciences · Ness Ziyyona, Israel · Founded 1997
Innovative non-invasive hemoglobin measurement solutions for blood banks and medical facilities MoreLess
OrSense is a medical technology company specializing in non-invasive hemoglobin measurement solutions. The company serves blood banks, hospitals, and other medical facilities, providing advanced devices that measure hemoglobin levels without the need for blood samples. Operating in the healthcare market, OrSense's business model revolves around the sale and distribution of its proprietary medical devices. Revenue is generated through direct sales, partnerships, and long-term service agreements with healthcare providers. The company's technology is particularly valuable in settings such as blood donation centers, intensive care units (ICUs), and operating rooms, where quick and accurate hemoglobin measurement is critical. OrSense's innovative approach not only enhances patient care but also improves operational efficiency for medical staff. Keywords: Non-invasive, Hemoglobin, Blood banks, Medical devices, Healthcare, ICU, Blood donation, Patient care, Hematology, Medical technology.
Company overview
OrSense company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 1997
- Headquarters
- Ness Ziyyona, Israel
- Employees
- 26
- Open positions
- None listed
- Dealroom signal
- 78.7
Valuation & funding
OrSense funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES HEquity / VC | Feb 2015 | $0 | — | Saints Capital | — |
| DEBTDebt | Jan 2014 | $0 | — | Saints Capital | — |
| GRANT✓Other financing | Jan 2013 | — | — | Eureka | — |
| LATE VC✓Equity / VC | May 2011 | $18M | $72M | Star Ventures · IHCV | — |
| GRANTOther financing | Aug 2001 | $0 | — | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 26 |
| 2025 | 25 |
| 2024 | 22 |
| 2023 | 24 |
| 2022 | 22 |
| 2021 | 21 |
| 2020 | 20 |
Growth signals
OrSense website traffic
Latest recorded traffic for OrSense is 2.1K monthly website visits, up 16.7% over the last three months. OrSense's team grew 4% over the past year.
Comparisons
OrSense compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
OrSense's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on OrSense's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where OrSense has talent and traffic
team presence
In the news
Latest news about OrSense
Recent press, funding announcements, and product moves mentioning OrSense — open to read from the original sources.
Market sentiment
What the market is saying about OrSense
An AI-synthesized read of the highest-engagement posts about OrSense on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OrSense’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.